MetaVia announces 1-for-11 reverse stock split effective Dec 4, 2025 to meet Nasdaq listing requirements

MetaVia Inc.

Reverse split at 1-for-11 ratio effective 5:00 p.m. ET Dec 4, 2025; begins split-adjusted trading Dec 5.
Outstanding shares reduced from ~25.4 million to ~2.3 million; authorized shares unchanged at 100 million.
Options, RSUs, and warrants adjusted proportionately; fractional shares rounded down for cash payment.
Approved by stockholders on June 30, 2025; board set ratio; new CUSIP 64132R 503; symbol remains MTVA.
MetaVia is a clinical-stage biotech focused on cardiometabolic diseases; no financial results reported.

item 3.03 item 5.03 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MetaVia Inc.: Amendment to Certificate of Incorporation to effect a 1-for-11 reverse stock split of common stock (effective 2025-12-04).

Change: charter amendment
Effective: 2025-12-04

Exact text from the filing

On December 2, 2025, the Company filed with the Secretary of State of the State of Delaware (the “Delaware Secretary of State”) a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

View on SEC.gov

241 governance changes filed in the last 30 days. Browse all governance changes →

MetaVia Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-117540

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.